fda compounding semaglutide warning letters october 2025 Troubling Findings in Study of GLP-1 Compounders Novo Nordisk Calls for FDA

Contraindications include a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome type 2 (MEN 2), or a known allergic reaction to the medication

A network meta-analysis published recently confirmed this pattern, finding that retatrutide demonstrated greater absolute weight reduction compared to tirzepatide (retatrutide: MD -16.34 kg vs tirzepatide: MD -11.82 kg)

Wharton S, et al

Saxenda dosing Saxenda is available in daily injectable doses of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg, and 3.0 mg

Typical Copay Ranges for Semaglutide Coverage for semaglutide can be very different depending on your health insurance provider and the commercial insurance plan you have

Dolores Catania While chatting with Andy Cohen in April 2023, the star of "The Real Housewives of New Jersey" said she had been taking Ozempic